Metadherin: A Therapeutic Target in Multiple Cancers
Conclusion
MTDH is pro-oncogenic factor playing multifaceted and diverse roles in cancer progression. Its association and central role in regulating signaling pathways such a MAPK, wnt/β-catenin, PI3K/AkT, NF-κβ pathways in various cancers shows that it plays a vital role in metastasis. MTDH contribution to chemo and radiotherapy resistance provides a new direction for the development of anticancer therapeutics. Multiple mechanisms converge to promote expression of MTDH in cancers. Further studies are therefore warranted to determine whether the elevated MTDH expression has prognostic value for development of the malignancy. Given its increased expression in many cancer types it would be important to determine whether MTDH represents a feasible target for cancer therapy, including immune-therapy. For these reasons there is now an urgent need to determine the clinical and therapeutic significance of increased MTDH expression in cancer.
Author Contributions
GD originated the idea for writing the review and wrote about MTDH association in different cancers. NS and MG wrote the following sections: micro RNAs regulation of MTDH expression and MTDH target for cancer therapy. ER, JL-R, and NM were involved in writing the MTDH regulation and molecular functions and preparing the original figures. RM and SK contributed to the clinical significance of MTDH expression in cancer. AR managed the different collaborations during the writing of the review and contr...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Academia | Alcoholism | Allergy & Immunology | Biology | Biotechnology | Bone Cancers | Brain | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Cancer Vaccines | Carcinoma | Carcinoma in Situ | Cervical Cancer | Chronic Leukemia | Chronic Lymphocytic Leukemia | Colon Cancer | Colorectal Cancer | Databases & Libraries | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Education | Endometrial Cancer | Epidemiology | Epithelial Cancer | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Head and Neck Cancer | Hepatitis | Hepatitis B | Hepatitis Vaccine | Hepatocellular Carcinoma | HER2 | Herceptin | HNSCC | Immunotherapy | India Health | Insulin | Leukemia | Liver | Liver Cancer | Lung Cancer | Men | Microbiology | Middle East Health | Molecular Biology | Myeloma | Neuroblastoma | Neurology | Neuroscience | Non-Small Cell Lung Cancer | Osteosarcoma | Ovarian Cancer | Ovaries | Prostate Cancer | Reproduction Medicine | Russia Health | Saudi Arabia Health | Science | Serous Carcinoma | Skin Cancer | Squamous Cell Carcinoma | Statistics | Stem Cell Therapy | Stem Cells | Study | Tamoxifen | Thyroid | Thyroid Cancer | Translocation | UK Health | Universities & Medical Training | University of Washington | Urology & Nephrology | USA Health | Vaccines | Velcade | Veterinary Research | Veterinary Vaccinations